SFARI | SFARI Funded Publications

UBE3A reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.

Silva-Santos S., van Woerden G.M., Bruinsma C.F., Mientjes E., Jolfaei M.A., Distel B., Kushner S.A., Elgersma Y.

Testing sensory and multisensory function in children with autism spectrum disorder.

Baum S.H., Stevenson R.A., Wallace M.

Methyl-CpG binding protein 2 regulates microglia and macrophage gene expression in response to inflammatory stimuli.

Cronk J., Derecki N.C., Ji E., Xu Y., Lampano A.E., Smirnov I., Baker W., Norris G.T., Marin I., Coddington N., Wolf Y., Turner S.D., Aderem A., Klibanov A.L., Harris T.H., Jung S., Litvak V., Kipnis J.

Closed-loop and activity-guided optogenetic control.

Grosenick L., Marshel J.H., Deisseroth K.

Loss of delta-catenin function in severe autism.

Turner T., Sharma K., Oh E.C., Liu Y.P., Collins R.L., Sosa M.X., Auer D.R., Brand H., Sanders S., Moreno-De-Luca D., Pihur V., Plona T., Pike K., Soppet D.R., Smith M.W., Cheung S.W., Martin C. L., State M., Talkowski M., Cook E. H., Huganir R., Katsanis N., Chakravarti A.

Language impairment and dyslexia genes influence language skills in children with autism spectrum disorders.

Eicher J.D., Gruen J.R.

Atypical hemispheric specialization for faces in infants at risk for autism spectrum disorder.

Keehn B., Vogel-Farley V., Tager-Flusberg H., Nelson C.

Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.

Vorstman J.A., Breetvelt E.J., Duijff S.N., Eliez S., Schneider M., Jalbrzikowski M., Armando M., Vicari S., Shashi V., Hooper S.R., Chow E.W., Fung W.L., Butcher N.J., Young D.A., McDonald-McGinn D.M., Vogels A., van Amelsvoort T., Gothelf D., Weinberger R., Weizman A., Klaassen P.W., Koops S., Kates W.R., Antshel K.M., Simon T.J., Ousley O., Swillen A., Gur R.E., Bearden C., Kahn R.S., Bassett A.S., International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome, Valdivia Espino J.

Systematic discovery of regulated and conserved alternative exons in the mammalian brain reveals nmd modulating chromatin regulators.

Yan Q., Weyn-Vanhentenryck S.M., Wu J., Sloan S.A., Zhang Y., Chen K., Wu J.Q., Barres B.A., Zhang C.

The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment.

Cotney J., Muhle R., Sanders S., Liu L., Willsey A.J., Niu W., Liu W., Klei L., Lei J., Yin J., Reilly S.K., Tebbenkamp A.T., Bichsel C., Pletikos M., Sestan N., Roeder K., State M., Devlin B., Noonan J.